Isoliquiritigenin attenuates doxorubicin-induced cardiomyopathy by alleviating mitochondrial dysfunction and oxidative damage through the Piezo1/Ca²⁺/Pdk4 signaling axis
Isoliquiritigenin attenuates doxorubicin-induced cardiomyopathy by alleviating mitochondrial dysfunction and oxidative damage through the Piezo1/Ca²⁺/Pdk4 signaling axis. // Phytomedicine. – URL: https://www.sciencedirect.com/science/article/pii/S0944711326011153?dgcid=rss_sd_all
Isoliquiritigenin attenuates doxorubicin-induced cardiomyopathy by alleviating mitochondrial dysfunction and oxidative damage through the Piezo1/Ca²⁺/Pdk4 signaling axis. Phytomedicine. https://www.sciencedirect.com/science/article/pii/S0944711326011153?dgcid=rss_sd_all
“Isoliquiritigenin attenuates doxorubicin-induced cardiomyopathy by alleviating mitochondrial dysfunction and oxidative damage through the Piezo1/Ca²⁺/Pdk4 signaling axis.” Phytomedicine.
@article{article62544,
title = {Isoliquiritigenin attenuates doxorubicin-induced cardiomyopathy by alleviating mitochondrial dysfunction and oxidative damage through the Piezo1/Ca²⁺/Pdk4 signaling axis},
journal = {Phytomedicine},
url = {https://www.sciencedirect.com/science/article/pii/S0944711326011153?dgcid=rss_sd_all}
}
Publication date: 8 December 2026 Source: Molecular Therapy Nucleic Acids, Volume 37, Issue 4 Author(s): Madison A. Schaefer, Brandon Wilbanks, Irene K. Yan, Alexis M. Sosic, Julia Driscoll, Rory L. Smoot, Tushar Patel, L. James Maher,...